Invention Grant
- Patent Title: Methods of using Salmonella enterica presenting C. jejuni N-glycan or derivatives thereof
-
Application No.: US15094537Application Date: 2016-04-08
-
Publication No.: US09764021B2Publication Date: 2017-09-19
- Inventor: Karin Ilg , Markus Aebi , Umesh Ahuja , Saba Amber , Flavio Schwartz
- Applicant: EIDGE-NOESSISCHE TECHNISCHE HOCHSCHULE ZURICHE
- Applicant Address: CH Zurich
- Assignee: EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
- Current Assignee: EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
- Current Assignee Address: CH Zurich
- Agency: Juneau & Mitchell
- Priority: EP9004445 20090327
- Main IPC: A01N63/00
- IPC: A01N63/00 ; A61K39/02 ; A61K39/112 ; C12N1/20 ; C12N1/36 ; A61K39/00
Abstract:
The present invention relates to Salmonella enterica comprising at least pgl operon of Campylobacter jejuni or a functional derivative thereof and presenting at least one N-glycan of Campylobacter jejuni or N-glycan derivative thereof on its cell surface and, in particular, to medical uses and pharmaceutical compositions thereof as well as methods for treating and/or preventing Campylobacter and optionally Salmonella infections and methods for producing these Salmonella strains.
Public/Granted literature
- US20160213770A1 Methods of using Salmonella enterica presenting C. Jejuni N-glycan or derivatives thereof Public/Granted day:2016-07-28
Information query
